COLLECTING DUCT CARCINOMA
Clinical trials for COLLECTING DUCT CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new COLLECTING DUCT CARCINOMA trials appear
Sign up with your email to follow new studies for COLLECTING DUCT CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare cancers: Triple-Threat therapy trial opens
Disease control Recruiting nowThis study is testing a combination of three drugs—cabozantinib, nivolumab, and ipilimumab—for patients with rare types of bladder, kidney, penile, and other urinary tract cancers that have spread. The goal is to see if this three-drug approach can shrink tumors and control the d…
Matched conditions: COLLECTING DUCT CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
New hope for rare kidney cancers: testing a powerful drug duo
Disease control Recruiting nowThis study is testing whether a combination of two drugs, pembrolizumab and enfortumab vedotin, can help control two rare and aggressive types of kidney cancer. It will enroll about 23 adults with advanced collecting duct carcinoma or renal medullary carcinoma. The main goal is t…
Matched conditions: COLLECTING DUCT CARCINOMA
Phase: PHASE2 • Sponsor: Giuseppe Procopio • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC